Accelerating Texas K12 Education: The Future of K12 Education

Podcast host JW Marshall welcomed guest Dr. Melana Silvia, former curriculum Director of Pre-K through 12 Math and Science program for the Calallen Independent School District, Corpus Christi, TX to discuss the past, present, and future state of education on the popular podcast Accelerating Texas K12 Education.

Dr. Silvia spent 33 years in education with 24 of those years spent working at Calallen. She retired in 2021 and became a training consultant for teachers. While no longer in the school buildings influencing district decisions, Dr. Silvia continues to help others positively impact education while improving students’ learning outcomes.

The discussion covered the breadth of challenges and opportunities brought on by the pandemic with a focus on how experiences and lessons learned will impact future generations. “Everyone struggled at the beginning, We didn’t have the background knowledge or the equipment to set up to start doing virtual learning,” Dr. Silvia noted.

She went on to discuss the challenges of returning to the classroom, virtual learning, technology, Texas House Bill 4545, and much more. Interestingly enough, one of the biggest challenges since returning is meeting the requirements of House Bill 4545 in a manner that truly helps students. What was surely intended to be helpful has placed a significant burden on teachers and administrators.

When asked about the future of students who thrived in a virtual environment, Dr. Silvia agreed that she personally knew “some families who thrived in the virtual setting.” And “moving forward I really feel like there needs to be that option. I don’t feel like it needs to be part of a public-school setting for every school district.”

Follow us on social media for the latest updates in B2B!

Image

Latest

cancer
Targeting T Cells Within the Cancer Immunity Cycle
April 19, 2025

As cancer immunotherapy continues to reshape treatment landscapes, fine-tuning T-cell responses has become a critical frontier. Recent advances in 3D organoid models and high-content imaging are enabling scientists to closely mimic patient-specific tumor environments—unlocking insights into how T cells behave, respond, and falter under immune checkpoint blockade. With over 4,000 immune modulators in clinical…

Read More
cancer Immunity cycle
Advanced In Vitro Technologies to Investigate Therapeutic Impact on the Cancer Immunity Cycle
April 19, 2025

As immunotherapy revolutionizes cancer treatment, the need for physiologically relevant preclinical models becomes more urgent than ever. Despite the success of immune checkpoint inhibitors, a large majority of patients fail to achieve long-lasting responses, prompting researchers to explore more complex and predictive assays. The cancer immunity cycle, first described in 2013, remains a central framework…

Read More
resistance
Inside Oncology Drug Development: Overcoming Resistance with Science
April 19, 2025

In the last two decades, oncology has undergone a transformation with over 300 new cancer therapies approved by the FDA—many offering novel mechanisms of action. Despite these innovations, resistance to treatment remains a critical challenge, with cancer cells evolving or adapting to evade even the most advanced therapeutics. This issue is particularly pressing given that…

Read More
organoids
Growing the Future of Cancer Research: Inside the Promise of Organoids
April 19, 2025

In an era where precision and predictability define the future of oncology, organoid technology is emerging as a transformative tool in drug discovery. These miniature, lab-grown 3D tissues mirror real human biology more closely than traditional 2D models or even animal systems, offering researchers the potential to predict patient-specific drug responses. As organoids become more…

Read More